A recent study has, however, demonstrated loss of ATM signaling to inhibit the growth of TP53-null tumor xenografts, via stabilization of p14ARF (Velimezi et al., 2013), suggesting that ATM function in cancer is highly context-dependent. The gene discussed is TP53; the disease is cancer.